
Bigatra 150mg Tablet
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Dabigatran Etexilate (150mg)
Overview Bigatra 150mg Tablet
Coagulase 150mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent thrombosis, it also mitigates clot risk post-knee or hip replacement. Administration is flexible—with or without food—but consistent daily timing is recommended. Long-term use, sometimes lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications, including diet, exercise, smoking cessation, and weight management, further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding susceptibility (nosebleeds, bruising). Report any adverse effects promptly. Additional potential side effects encompass headaches, seizures, allergic responses, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.
Uses of Bigatra 150mg Tablet
Managing and averting blood clot formation.
Major Benefits of Bigatra 150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bigatra 150mg Tablets can be consumed with or without food; however, consistent timing is recommended.
Common Side effects of Bigatra 150mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Bigatra 150mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bigatra 150mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Bigatra 150mg Tablet works:
Bloxgard 150mg tablets are a new type of oral blood thinner. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Bigatra 150mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Bigatra 150mg Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the benefits against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Bigatra 150mg Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Bigatra 150mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Bigatra 150mg Tablets, as dosage modification may be necessary. Consult a physician before use. Bigatra 150mg Tablets are generally unsuitable for individuals with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should use Bigatra 150mg Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bigatra 150mg Tablet :
Should you forget a Bigatra 150mg Tablet dose, ingest it immediately, if still within the same day. However, omit the missed dose if less than 6 hours remain until the next scheduled intake. Never compensate for a missed dose by doubling the subsequent one.
Facts to Know About Bigatra 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Oral direct thrombin inhibitor |
